10 research outputs found

    PyDPI: Freely Available Python Package for Chemoinformatics, Bioinformatics, and Chemogenomics Studies

    No full text
    The rapidly increasing amount of publicly available data in biology and chemistry enables researchers to revisit interaction problems by systematic integration and analysis of heterogeneous data. Herein, we developed a comprehensive python package to emphasize the integration of chemoinformatics and bioinformatics into a molecular informatics platform for drug discovery. PyDPI (drug–protein interaction with Python) is a powerful python toolkit for computing commonly used structural and physicochemical features of proteins and peptides from amino acid sequences, molecular descriptors of drug molecules from their topology, and protein–protein interaction and protein–ligand interaction descriptors. It computes 6 protein feature groups composed of 14 features that include 52 descriptor types and 9890 descriptors, 9 drug feature groups composed of 13 descriptor types that include 615 descriptors. In addition, it provides seven types of molecular fingerprint systems for drug molecules, including topological fingerprints, electro-topological state (E-state) fingerprints, MACCS keys, FP4 keys, atom pair fingerprints, topological torsion fingerprints, and Morgan/circular fingerprints. By combining different types of descriptors from drugs and proteins in different ways, interaction descriptors representing protein–protein or drug–protein interactions could be conveniently generated. These computed descriptors can be widely used in various fields relevant to chemoinformatics, bioinformatics, and chemogenomics. PyDPI is freely available via https://sourceforge.net/projects/pydpicao/

    Prediction of Peptide Fragment Ion Mass Spectra by Data Mining Techniques

    No full text
    Accurate prediction of peptide fragment ion mass spectra is one of the critical factors to guarantee confident peptide identification by protein sequence database search in bottom-up proteomics. In an attempt to accurately and comprehensively predict this type of mass spectra, a framework named MS<sup>2</sup>PBPI is proposed. MS<sup>2</sup>PBPI first extracts fragment ions from large-scale MS/MS spectra data sets according to the peptide fragmentation pathways and uses binary trees to divide the obtained bulky data into tens to more than 1000 regions. For each adequate region, stochastic gradient boosting tree regression model is constructed. By constructing hundreds of these models, MS<sup>2</sup>PBPI is able to predict MS/MS spectra for unmodified and modified peptides with reasonable accuracy. Moreover, high consistency between predicted and experimental MS/MS spectra derived from different ion trap instruments with low and high resolving power is achieved. MS<sup>2</sup>PBPI outperforms existing algorithms MassAnalyzer and PeptideART

    Prediction results of five-fold cross validation using different models.

    No full text
    <p>TP: true positives; FN: false negatives; TN: true negatives; FP: false positives; Sen: sensitivity; Spe: specificity; Acc: accuracy.</p

    ROCs and precision-recall curves with different K<sub>i</sub> thresholds using RF.

    No full text
    <p>(A) ROCs (B) precision-recall curves. The auPRCs drop with the decreasing of K<sub>i</sub> thresholds. However, the varying trend of auROCs is consistent with that of auPRCs.</p

    Drug-target interaction network using drug-target pairs with prediction probability above 0.99.

    No full text
    <p>Drugs and targets are presented by red circle and blue triangle, respectively. Drug-target interactions are represented by the edges connecting related drugs and targets.</p

    The plot of K<sub>i</sub> versus prediction probability on 5-fold cross validation.

    No full text
    <p>non-interaction: red and interaction: green. Linear relationship between K<sub>i</sub> and prediction probability could be observed with correlation coefficient of 0.65.</p

    Outline of our methodology.

    No full text
    <p>(A) Interaction features are calculated by combing the fingerprint descriptors from drugs and the CTD and amino acid composition descriptors from protein sequences. These feature vectors are used to find the optimal RF parameters which most accurately separate the positive and negative training sets. The independent validation sets are used for further validation for the RF model. (B) Once the RF model is constructed, we can predict new unknown drug-target associations or screen all cross-linking associations.</p

    Prediction statistics on different false discovery rates.

    No full text
    <p>FDR: false discovery rate, Number: Number of drug-target pairs predicted as interactions, Ratio: the ratio between drug target pairs predicted as interactions and all screening pairs on specific FDR.</p
    corecore